Koning F - Search Results

1

Synaptojanin 2 is recognized by HLA class II-restricted hairy cell leukemia-specific T cells.

Spaenij-Dekking EH, Van Delft J, Van Der Meijden E, Hiemstra HS, Falkenburg JH, Koning F, Drijfhout JW, Kluin-Nelemans JC. Spaenij-Dekking EH, et al. Among authors: koning f. Leukemia. 2003 Dec;17(12):2467-73. doi: 10.1038/sj.leu.2403174. Leukemia. 2003. PMID: 14562116

2

HLA class II expression on human epidermal Langerhans cells in situ: upregulation during the elicitation of allergic contact dermatitis.

Mommaas AM, Wijsman MC, Mulder AA, van Praag MC, Vermeer BJ, Koning F. Mommaas AM, et al. Among authors: koning f. Hum Immunol. 1992 Jun;34(2):99-106. doi: 10.1016/0198-8859(92)90035-l. Hum Immunol. 1992. PMID: 1429038

3

Selective removal of clonogenic neoplastic B cells from human bone marrow using anti-HLA-DQ antibodies and complement.

Falkenburg JH, Fibbe WE, Veenhof WF, Koning F, van Eeden G, Voogt PJ, Jansen J. Falkenburg JH, et al. Among authors: koning f. Exp Hematol. 1986 Feb;14(2):101-7. Exp Hematol. 1986. PMID: 2417877

4

Expression of CD11, CDw15, and transferrin receptor antigens on human hematopoietic progenitor cells.

Falkenburg JH, Koning F, Duinkerken N, Fibbe WE, Voogt PJ, Jansen J. Falkenburg JH, et al. Among authors: koning f. Exp Hematol. 1986 Feb;14(2):90-6. Exp Hematol. 1986. PMID: 3002833

5

Identification of a graft versus host disease-associated human minor histocompatibility antigen.

den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH, et al. den Haan JM, et al. Among authors: koning f. Science. 1995 Jun 9;268(5216):1476-80. doi: 10.1126/science.7539551. Science. 1995. PMID: 7539551

6

Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing.

Verreck FA, van de Poel A, Termijtelen A, Amons R, Drijfhout JW, Koning F. Verreck FA, et al. Among authors: koning f. Eur J Immunol. 1994 Feb;24(2):375-9. doi: 10.1002/eji.1830240216. Eur J Immunol. 1994. PMID: 8299686

7

Isolation of an HLA-A2.1 extracted human minor histocompatibility peptide.

de Bueger M, Verreck F, Blokland E, Drijfhout JW, Amons R, Koning F, Goulmy E. de Bueger M, et al. Among authors: koning f. Eur J Immunol. 1993 Mar;23(3):614-8. doi: 10.1002/eji.1830230305. Eur J Immunol. 1993. PMID: 8449209

8

The generation of SDS-stable HLA DR dimers is independent of efficient peptide binding.

Verreck FA, Vermeulen C, Poel AV, Jorritsma P, Amons R, Coligan JE, Drijfhout JW, Koning F. Verreck FA, et al. Among authors: koning f. Int Immunol. 1996 Mar;8(3):397-404. doi: 10.1093/intimm/8.3.397. Int Immunol. 1996. PMID: 8671626

9

Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule.

van de Wal Y, Kooy YM, Drijfhout JW, Amons R, Koning F. van de Wal Y, et al. Among authors: koning f. Immunogenetics. 1996;44(4):246-53. doi: 10.1007/BF02602553. Immunogenetics. 1996. PMID: 8753854

10

Mannose receptor mediated uptake of antigens strongly enhances HLA-class II restricted antigen presentation by cultured dendritic cells.

Tan MC, Mommaas AM, Drijfhout JW, Jordens R, Onderwater JJ, Verwoerd D, Mulder AA, van der Heiden AN, Ottenhoff TH, Cella M, Tulp A, Neefjes JJ, Koning F. Tan MC, et al. Among authors: koning f. Adv Exp Med Biol. 1997;417:171-4. doi: 10.1007/978-1-4757-9966-8_28. Adv Exp Med Biol. 1997. PMID: 9286356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters